IDEXX Laboratories Inc (IDXX)
IDEXX Laboratories Inc is a healthcare equipment and supplies company listed on NASDAQ as common stock under the ticker IDXX. The company develops, manufactures, and distributes diagnostics and related products for companion animals, livestock and poultry, dairy, and water testing markets in the United States and internationally. Its operations are organized into three segments: Companion Animal Group, Water Quality Products, and Livestock, Poultry and Dairy.
The company’s companion animal portfolio includes point-of-care diagnostic systems, blood and urine chemistry analyzers, hematology and immunoassay instruments, urinalysis and cytology tools, coagulation analyzers, and SNAP rapid test kits. IDEXX also provides reference laboratory testing, veterinary consulting, telemedicine, imaging-related advisory services, and software for veterinary clinics and corporate groups. In water testing, it offers products designed to detect total coliforms and E. coli, along with related instruments and consumables. The company also serves livestock and poultry customers with diagnostic tests, services, and instrumentation, and markets its products through direct sales, customer service, technical support, distributors, and resellers. IDEXX was incorporated in 1983 and is headquartered in Westbrook, Maine.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-IDXX
|
$522.60
|
-6.7% Downside
|
Fair
|
$698
|
24.6% Upside
|
Undervalued
|
Great
|
0.0%
|
38.7x
|
27.4x
|
9.7x
|
44.147 B
|
45.047 B
|
2.4%
|
99.6%
|
21.1
|
110.1%
|